rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2004-7-12
|
pubmed:abstractText |
The aim of this study was to evaluate the safety and efficacy of allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen (RIST) for interferon-alpha-refractory metastatic renal cell carcinoma (RCC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0301-472X
|
pubmed:author |
pubmed-author:FujimotoHiroyukiH,
pubmed-author:HamakiTamaeT,
pubmed-author:HoriAkikoA,
pubmed-author:KakizoeTadaoT,
pubmed-author:KamiMasahiroM,
pubmed-author:KimSung-WonSW,
pubmed-author:KishiYukikoY,
pubmed-author:KomiyamaMotokiyoM,
pubmed-author:MakimotoAtsushiA,
pubmed-author:MatsuokaNaokiN,
pubmed-author:MoriShinichiroS,
pubmed-author:MurashigeNaokoN,
pubmed-author:NakagawaTohruT,
pubmed-author:OkajimaEijiroE,
pubmed-author:TajimaKinukoK,
pubmed-author:TakaueYoichiY,
pubmed-author:TanosakiRyujiR,
pubmed-author:TobisuKen-ichiK,
pubmed-author:UikeNaokuniN,
pubmed-author:WakayamaToshioT
|
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
599-606
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15246155-Acute Disease,
pubmed-meshheading:15246155-Adult,
pubmed-meshheading:15246155-Carcinoma, Renal Cell,
pubmed-meshheading:15246155-Chronic Disease,
pubmed-meshheading:15246155-Female,
pubmed-meshheading:15246155-Follow-Up Studies,
pubmed-meshheading:15246155-Graft vs Host Disease,
pubmed-meshheading:15246155-Histocompatibility Testing,
pubmed-meshheading:15246155-Humans,
pubmed-meshheading:15246155-Kidney Neoplasms,
pubmed-meshheading:15246155-Male,
pubmed-meshheading:15246155-Middle Aged,
pubmed-meshheading:15246155-Neoplasm Metastasis,
pubmed-meshheading:15246155-Neoplasm Staging,
pubmed-meshheading:15246155-Nephrectomy,
pubmed-meshheading:15246155-Patient Selection,
pubmed-meshheading:15246155-Retrospective Studies,
pubmed-meshheading:15246155-Stem Cell Transplantation,
pubmed-meshheading:15246155-Survival Analysis,
pubmed-meshheading:15246155-Time Factors,
pubmed-meshheading:15246155-Transplantation, Homologous,
pubmed-meshheading:15246155-Transplantation Conditioning,
pubmed-meshheading:15246155-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up.
|
pubmed:affiliation |
Urology Division, National Cancer Center Hospital, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|